28.59MMarket Cap-7019P/E (TTM)
3.750High3.570Low32.67KVolume3.660Open3.630Pre Close119.61KTurnover0.69%Turnover RatioLossP/E (Static)7.83MShares5.59052wk High1.22P/B17.20MFloat Cap3.34052wk Low--Dividend TTM4.71MShs Float13.200Historical High--Div YieldTTM4.96%Amplitude1.000Historical Low3.661Avg Price1Lot Size
ImmuCell Stock Forum
ImmuCell Corporation (Nasdaq: ICCC), a key player in the animal health industry, has recently announced its preliminary, unaudited sales results for the first quarter of 2024, and the figures are nothing short of impressive. With a staggering 111% increase in sales compared to the same period in 2023, and a 42% increase from the last quarter of ...
No comment yet